These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37453366)

  • 1. Explainable artificial intelligence to predict and identify prostate cancer tissue by gene expression.
    Ramírez-Mena A; Andrés-León E; Alvarez-Cubero MJ; Anguita-Ruiz A; Martinez-Gonzalez LJ; Alcala-Fdez J
    Comput Methods Programs Biomed; 2023 Oct; 240():107719. PubMed ID: 37453366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an explainable artificial intelligence-based decision-supporting tool for prostate biopsy.
    Suh J; Yoo S; Park J; Cho SY; Cho MC; Son H; Jeong H
    BJU Int; 2020 Dec; 126(6):694-703. PubMed ID: 32455477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study.
    Zhang H; Ji J; Liu Z; Lu H; Qian C; Wei C; Chen S; Lu W; Wang C; Xu H; Xu Y; Chen X; He X; Wang Z; Zhao X; Cheng W; Chen X; Pang G; Yu G; Gu Y; Jiang K; Xu B; Chen J; Xu B; Wei X; Chen M; Chen R; Cheng J; Wang F
    BMC Med; 2023 Jul; 21(1):270. PubMed ID: 37488510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Risk Prediction and Online Calculation Based on Machine Learning Algorithm.
    Wang C; Chang QX; Wang XM; Wang KY; Wang H; Cui Z; Li CP
    Chin Med Sci J; 2022 Sep; 37(3):210-217. PubMed ID: 36321176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explainable artificial intelligence model for identifying COVID-19 gene biomarkers.
    Yagin FH; Cicek İB; Alkhateeb A; Yagin B; Colak C; Azzeh M; Akbulut S
    Comput Biol Med; 2023 Mar; 154():106619. PubMed ID: 36738712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.
    Eiro N; Medina A; Gonzalez LO; Fraile M; Palacios A; Escaf S; Fernández-Gómez JM; Vizoso FJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence in Magnetic Resonance Imaging-based Prostate Cancer Diagnosis: Where Do We Stand in 2021?
    Suarez-Ibarrola R; Sigle A; Eklund M; Eberli D; Miernik A; Benndorf M; Bamberg F; Gratzke C
    Eur Urol Focus; 2022 Mar; 8(2):409-417. PubMed ID: 33773964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI.
    Hamm CA; Baumgärtner GL; Biessmann F; Beetz NL; Hartenstein A; Savic LJ; Froböse K; Dräger F; Schallenberg S; Rudolph M; Baur ADJ; Hamm B; Haas M; Hofbauer S; Cash H; Penzkofer T
    Radiology; 2023 May; 307(4):e222276. PubMed ID: 37039688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
    Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
    Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Cardiovascular Disease Risk Factors in Adults with Explainable Artificial Intelligence.
    Kırboğa KK; Küçüksille EU
    Anatol J Cardiol; 2023 Nov; 27(11):657-663. PubMed ID: 37624075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of anemic condition in patients from clinical markers and explainable artificial intelligence.
    Darshan BSD; Sampathila N; Bairy MG; Belurkar S; Prabhu S; Chadaga K
    Technol Health Care; 2024; 32(4):2431-2444. PubMed ID: 38339945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation.
    Kan Y; Zhang Q; Hao J; Wang W; Zhuang J; Gao J; Huang H; Liang J; Marra G; Calleris G; Oderda M; Zhao X; Gontero P; Guo H
    Eur Radiol; 2020 Nov; 30(11):6274-6284. PubMed ID: 32524222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CVD22: Explainable artificial intelligence determination of the relationship of troponin to D-Dimer, mortality, and CK-MB in COVID-19 patients.
    Kırboğa KK; Küçüksille EU; Naldan ME; Işık M; Gülcü O; Aksakal E
    Comput Methods Programs Biomed; 2023 May; 233():107492. PubMed ID: 36965300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial intelligence for target prostate biopsy outcomes prediction the potential application of fuzzy logic.
    Checcucci E; Rosati S; De Cillis S; Vagni M; Giordano N; Piana A; Granato S; Amparore D; De Luca S; Fiori C; Balestra G; Porpiglia F
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):359-362. PubMed ID: 34480083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell subtypes analyzed using artificial intelligence algorithm for predicting biochemical recurrence, immune escape potential, and immunotherapy response of prostate cancer.
    Xie X; Dou CX; Luo MR; Zhang K; Liu Y; Zhou JW; Huang ZP; Xue KY; Liang HY; Ouyang AR; Ma SX; Yang JK; Zhou QZ; Guo WB; Liu CD; Zhao SC; Chen MK
    Front Immunol; 2022; 13():946209. PubMed ID: 36569837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing artificial intelligence for prostate cancer management.
    Zhu L; Pan J; Mou W; Deng L; Zhu Y; Wang Y; Pareek G; Hyams E; Carneiro BA; Hadfield MJ; El-Deiry WS; Yang T; Tan T; Tong T; Ta N; Zhu Y; Gao Y; Lai Y; Cheng L; Chen R; Xue W
    Cell Rep Med; 2024 Apr; 5(4):101506. PubMed ID: 38593808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Random forest-based modelling to detect biomarkers for prostate cancer progression.
    Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
    Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An active learning based classification strategy for the minority class problem: application to histopathology annotation.
    Doyle S; Monaco J; Feldman M; Tomaszewski J; Madabhushi A
    BMC Bioinformatics; 2011 Oct; 12():424. PubMed ID: 22034914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches.
    Alarcón-Zendejas AP; Scavuzzo A; Jiménez-Ríos MA; Álvarez-Gómez RM; Montiel-Manríquez R; Castro-Hernández C; Jiménez-Dávila MA; Pérez-Montiel D; González-Barrios R; Jiménez-Trejo F; Arriaga-Canon C; Herrera LA
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):431-443. PubMed ID: 35422101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.